This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

When to offer testing (test) for coeliac disease

Authoring team

  • Offer serological testing for coeliac disease to:

    • people with any of the following:
      • persistent unexplained abdominal or gastrointestinal symptoms

      • faltering growth prolonged fatigue

      • unexpected weight loss

      • severe or persistent mouth ulcers

      • unexplained iron, vitamin B12 or folate deficiency

      • type 1 diabetes, at diagnosis

      • autoimmune thyroid disease, at diagnosis

      • irritable bowel syndrome (in adults)

    • first-degree relatives of people with coeliac disease

  • Consider serological testing for coeliac disease in people with any of the following:

    • metabolic bone disorder (reduced bone mineral density or osteomalacia)

    • unexplained neurological symptoms (particularly peripheral neuropathy or ataxia)

    • unexplained subfertility or recurrent miscarriage

    • persistently raised liver enzymes with unknown cause

    • dental enamel defects

    • Down's syndrome

    • Turner syndrome

Healthcare professionals should have a low threshold for re-testing people identified in recommendations if they develop any symptoms consistent with coeliac disease

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.